Medical specialists from Netherlands tagged as investigators in clinical trials studying Breast Neoplasms
Total 147 results
-
H M Oosterkamp, MDSeen in:
- Leidschendam, Haaglanden MC
Trials:- NCT01898117 (Principal Investigator)
Conditions: -
H van Halteren, MDSeen in:
- Goes, Admiraal de Ruyter Ziekenhuis
Trials:- NCT01898117 (Principal Investigator)
Conditions: -
H.W.M. van Laarhoven, MdSeen in:
- Gelderland, Nijmegen, Radboud University Nijmegen Medical Centre
- Gelderland, Nijmegen, University Medical Centre Nijmegen
Trials:- NCT01292408 (Sub-Investigator)
- NCT01246856 (Principal Investigator)
- NCT01329068 (Principal Investigator)
Conditions: -
Helena M Verkooijen, MD, PhDSeen in:
- Utrecht, University Medical Center Utrecht
Trials:- NCT02839863 (Principal Investigator)
- NCT04307914 (Principal Investigator)
- NCT04075305 (Principal Investigator)
Conditions:- Breast Cancer;
- Quality of Life;
- Pain;
- Neoplasm Metastasis;
- Bone Cancer;
- Bone Metastases;
- Tumor;
- Bone Neoplasm;
- Bone Lesion;
- Cancer Induced Bone Pain;
- Neoplasms;
- Head and Neck Cancer;
- Head and Neck Neoplasms;
- Gynecologic Cancer;
- Liver Neoplasms;
- Pancreatic Neoplasms;
- Pancreatic Cancer;
- Esophageal Cancer;
- Lung Cancer;
- Rectal Cancer;
- Rectal Neoplasms;
- Prostate Cancer;
- Brain Cancer;
- Brain Tumor;
- Bladder Cancer;
- Liver Metastases;
- Radiation Toxicity;
- Liver Cancer;
- Oncology;
- Prostate Neoplasm;
- Head and Neck Tumor;
- Oligometastases;
- Esophageal Neoplasm;
- Esophagus Cancer;
- Lung Neoplasm;
- Breast Tumor;
- Rectal Tumor;
- Pancreatic Tumor;
- Esophageal Tumor;
- Gynecologic Tumor;
- Prostate Tumor;
- Lung Tumor;
- Esophagus Tumor;
- Esophagus Neoplasm;
- Bladder Neoplasm
-
Henk-Jan Slooten van, MD, PhDSeen in:
- Noord-Holland, Alkmaar, Medical Center Alkmaar
Trials:- NCT02187718 (Sub-Investigator)
Conditions: -
Hermien Schreurs, MD, PhDSeen in:
- Noord-Holland, Alkmaar, Medical Center Alkmaar
Trials:- NCT02187718 (Principal Investigator)
Conditions: -
I Konings, MDSeen in:
- Amsterdam, AZVU
Trials:- NCT02810743 (Principal Investigator)
Conditions: -
I M Oving, MDSeen in:
- Almelo, ZGT
Trials:- NCT01898117 (Principal Investigator)
Conditions: -
I R Konings, MDSeen in:
- Amsterdam, AZVU
Trials:- NCT01898117 (Principal Investigator)
Conditions: -
Ioannis Sechopoulos, PhDSeen in:
- Gelderland, Nijmegen, Radboudumc
Trials:- NCT05458427 (Principal Investigator)
Conditions: -
J Heijns, MDSeen in:
- Breda, Amphia
Trials:- NCT01898117 (Principal Investigator)
Conditions: -
J R Kroep, MDSeen in:
- Leiden, LUMC
- Zuid-Holland, Leiden, Leiden University Medical Center
Trials:- NCT01898117 (Principal Investigator)
- NCT02810743 (Principal Investigator)
- NCT06193525 (Principal Investigator)
Conditions: -
J Tol, MDSeen in:
- Eindhoven, Jeroen Bosch Ziekenhuis
Trials:- NCT01898117 (Principal Investigator)
Conditions: -
J Zuetenhorst, MDSeen in:
- Rotterdam, Stichting Franciscus Vlietland Groep locatie Gasthuis
Trials:- NCT01898117 (Principal Investigator)
Conditions: -
J. HeijnsSeen in:
- Breda, Amphia Ziekenhuis
Trials:- NCT05503108 (Principal Investigator)
-
J. TolSeen in:
- Den Bosch, Jeroen Bosch Ziekenhuis
Trials:- NCT05503108 (Principal Investigator)
-
Jan Drooger, MDSeen in:
- Rotterdam, Ikazia Hospital Rotterdam
Trials:- NCT04796324 (Principal Investigator)
Conditions: -
Janneke Swart-HeikensSeen in:
- Drenthe, Assen, Wilhelmina Ziekenhuis Assen
Trials:- NCT05514054 (Principal Investigator)
Conditions: -
Joan Barbara HeijnsSeen in:
- Noord-Brabant, Breda, Amphia Ziekenhuis, locatie Breda Molengracht
Trials:- NCT05514054 (Principal Investigator)
Conditions: -
Jourik A Gietema, Prof. dr.Seen in:
- Groningen, University Medical Center Groningen
Trials:- NCT05851053 (Principal Investigator)
Conditions: -
Judith R Kroep, PhDSeen in:
- Leiden, Leiden University Medical Center
Trials:- NCT05503108 (Principal Investigator)
-
K Beelen, MDSeen in:
- Delft, Reinier de Graaf Gasthuis
Trials:- NCT01898117 (Principal Investigator)
Conditions: -
L Strobbe, MDSeen in:
- Apeldoorn, Gelre Ziekenhuis
Trials:- NCT01898117 (Principal Investigator)
Conditions: -
L. HammingSeen in:
- Leeuwarden, Medisch Centrum Leeuwarden
Trials:- NCT05503108 (Principal Investigator)
-
L. KesselsSeen in:
- Deventer, Deventer Ziekenhuis
Trials:- NCT05503108 (Principal Investigator)
-
L. Koppert, MD, PhDSeen in:
- Rotterdam, Erasmus Medical Center
Trials:- NCT05263362 (Sub-Investigator)
-
Laetitia LambertsSeen in:
- Drenthe, Assen, Wilhelmina Ziekenhuis Assen
Trials:- NCT05514054 (Principal Investigator)
Conditions:
Clinical Trials on Breast Neoplasms
-
Seagen Inc.CompletedTriple Negative Breast Neoplasms | Hormone Receptor Positive Breast Neoplasms | HER2 Positive Breast Neoplasms | HER2 Mutations Breast NeoplasmsUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Celgene CorporationTerminatedInflammatory Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Recurrent Breast Cancer | HER2-negative Breast CancerUnited States
-
Dana-Farber Cancer InstituteConquer Cancer FoundationRecruitingBreast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | Inflammatory Breast Cancer | Hormone Receptor Positive Malignant Neoplasm of BreastUnited States
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited States, Spain, Israel, Canada, Belgium, United Kingdom, France, Tunisia
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited States, Canada, Germany, Spain, Taiwan, Belgium, Philippines, Israel, Hong Kong, Thailand, Pakistan, Russian Federation, Italy, Romania, China, France, Peru, United Kingdom, Czech Republic, Australia, Chile, Korea, Republic of and more
-
Innocrin PharmaceuticalCompletedBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | Male Breast Cancer | ER+ Breast Cancer | Cancer of the BreastUnited States
-
Oslo University HospitalKarolinska Institutet; Hoffmann-La Roche; Rigshospitalet, Denmark; Helse Stavanger... and other collaboratorsCompletedTriple Negative Breast Cancer | Cancer, BreastNorway, Denmark
-
MedSIRHoffmann-La RocheCompletedAdvanced Breast Cancer | Metastatic Breast Cancer | Triple Negative Breast CancerSpain, France, United Kingdom, Germany, Italy
-
Centro Hospitalar Lisboa OcidentalInstituto Nacional de Medicina Legal e Ciências Forenses, Delegação do SulUnknownMale Breast Cancer | Female Breast Cancer
-
G1 Therapeutics, Inc.TerminatedBreast Cancer | Breast Neoplasm | Triple-Negative Breast Cancer | Triple-Negative Breast NeoplasmsUnited States, Bulgaria, Croatia, Slovenia, Serbia, Belgium, North Macedonia, Slovakia